Cytokinetics (CYTK) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CYTK Cytokinetics

Watchlist

49.010
-0.850-1.70%

Trading Nov 21 11:30 ET

5.78BMarket Cap-9109P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Mizuho Maintains Outperform on Cytokinetics, Raises Price Target to $103
BenzingaNov 21 08:10 ET · Ratings
Express News | Cytokinetics Inc : Mizuho Raises Target Price to $103 From $99
ReutersNov 21 06:46 ET
Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
Zacks Nov 21 02:29 ET
Unusual Options Activity: MET, CNH and Others Attract Market Bets, MET V/OI Ratio Reaches 318.2
Moomoo NewsNov 20 13:30 ET
A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $70 to $120
Moomoo NewsNov 20 08:00 ET · Ratings
Cytokinetics' Hold Rating Amid Bayer Partnership and Acquisition Uncertainty
TipRanksNov 20 06:16 ET · Ratings

Comments

Sean Parker

Nov 19 02:56

$Cytokinetics (CYTK.US)$
Cytokinetics (CYTK) and Bayer have established an exclusive licensing agreement for aficamten in Japan, focusing on treating hypertrophic cardiomyopathy (HCM). The deal includes an upfront payment of €50 million to Cytokinetics, with potential additional earnings of €90 million in milestones through commercial launch (including €20 million near-term) and up to €490 million in commercial milestone payments. The collaboration involves tiered royalties on Japanese sales and ...

Mr Long Term

Aug 13 17:42

Columns Top Calls on Wall Street: Starbucks, Dell, Warner Bros. and More.

Top 5 Upgrades:
Baird upgraded Starbucks $Starbucks (SBUX.US)$ to Outperform from Neutral with a price target of $110, up from $81. The firm sees a more favorable risk/reward on Starbucks shares following the hiring of Brian Niccol as CEO.
Barclays upgraded Dell Technologies $Dell Technologies (DELL.US)$ to Equal Weight from Underweight with an unchanged price target of $97. The firm says much of the artificial intelligence "hype" ...